EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Perioperative outcomes after open biliary bypass for malignant biliary obstruction (MBO) in resource-limited setups; a multicenter prospective cohort study, 2023

Yoseph Solomon Bezabih, Shimelis Nigussie Gebremariam

European Journal of Surgical Oncology · 2024

DOI: 10.1016/j.ejso.2024.108254 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2024. Verfasst von Yoseph Solomon Bezabih und 1 weiteren Autor:innen. Beteiligte Einrichtung: Addis Ababa University College of Health Sciences Surgery, Ethiopia. Electronic address: josephsol87@gmail.com. Hauptthemen laut MEDLINE: Jaundice, Obstructive, Cholangitis, Cholestasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Obstructive jaundice is the most common symptom of malignant diseases of the extrahepatic biliary system and necessitates either non-operative or operative biliary bypass. Because of percutaneous and endoscopic approaches, the use of palliative surgical procedures has decreased in recent years. However, in resource-limited situations, open biliary bypasses remain a viable option. This study aimed to identify factors associated with adverse perioperative outcomes following open biliary bypass. METHODS: From June 2022 to May 2023, 69 patients underwent open biliary bypass for malignant biliary obstruction. Postoperative morbidity and mortality within 30 days of surgery were assessed. A Kaplan-Meier was used for categorical variables, and a log-rank test was used to determine the statistically significant difference between variables. A Cox regression analysis was conducted to identify factors associated to time to develop complications. RESULTS: The hazard of developing complications among those with preoperative cholangitis was 2.49 times higher than those without preoperative cholangitis (HR 2.49, 95% CI [1.06, 5.84]). For every hour increment in the length of surgery, the hazard of getting complications increased by 2.47 times (HR 2.47, 95% CI [1.28, 4.77]). As serum bilirubin increased by 1 mg/dl, the hazard of developing complications increased by 14% (HR 1.14, 95% CI [1.03, 1.17]). CONCLUSION: Patients who had long operation times, preoperative cholangitis, and elevated total bilirubin levels are at increased risk for poor perioperative outcomes. Clinicians may use these results to optimize these patients to decrease their elevated risk of serious morbidity and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Jaundice, ObstructiveCholangitisCholestasisHumansProspective StudiesBilirubinDrainage

Stichwörter der Autor:innen

Malignant biliary obstructionOpen biliary bypassPerioperative outcomes

Substanzen

Bilirubin

Autor:innen und Institutionen

  • Addis Ababa University College of Health Sciences Surgery, Ethiopia. Electronic address: josephsol87@gmail.com.
  • Addis Ababa University College of Health Sciences Surgery, Ethiopia. Electronic address: drshimelisnig@gmail.com.

Zitieren

APA

Bezabih, Y. S., & Gebremariam, S. N. (2024). Perioperative outcomes after open biliary bypass for malignant biliary obstruction (MBO) in resource-limited setups; a multicenter prospective cohort study, 2023. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2024.108254

Vancouver

Bezabih YS, Gebremariam SN. Perioperative outcomes after open biliary bypass for malignant biliary obstruction (MBO) in resource-limited setups; a multicenter prospective cohort study, 2023. European Journal of Surgical Oncology. 2024. doi:10.1016/j.ejso.2024.108254

BibTeX
@article{Bezabih2024,
  author = {Bezabih, Yoseph Solomon and Gebremariam, Shimelis Nigussie},
  title = {Perioperative outcomes after open biliary bypass for malignant biliary obstruction (MBO) in resource-limited setups; a multicenter prospective cohort study, 2023},
  journal = {European Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1016/j.ejso.2024.108254}
}
Kostenlos starten →